GLP-1 receptor agonists enhance glucose-dependent insulin secretion from pancreatic beta cells while suppressing inappropriate glucagon release, thereby improving glycemic control
GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling
By August 2024, that number had risen nearly tenfold to more than 1.8 million monthly approved claims
Other potential risks Skin reactions: Adhesives and herbal extracts may cause irritation, rashes, or allergic responses that can last for days
Theyre different stimulant medications, but all prescription stimulants can be abused and addictive
Mechanistic studies, such as the ongoing retatrutide iohexol-derived GFR study (NCT05936151), are required to better understand the physiological pathways underlying the effects of retatrutide on GFR over time and may help explain differences between patient populations